Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAGRAXOFUSP-ERZS: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

22.8%
Female
77.2%
Male

Age Information

The average age of patients reporting adverse events with TAGRAXOFUSP-ERZS is 65.9 years.

Geographic Distribution

The majority of adverse event reports for TAGRAXOFUSP-ERZS originate from US.

Report Summary & Outcomes

438
Total Reports
438
As Primary/Secondary Suspect
114
Deaths Reported
116
Hospitalizations
25
Life-Threatening
8
Disabilities

Reporting Timeline

First adverse event report: 20000209. Most recent report: 20250915. View full timeline →

More About TAGRAXOFUSP-ERZS

TAGRAXOFUSP-ERZS Full Profile Reports by Year Drug Interactions